🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bone Sarcoma

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago · Tests: Cytalux Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma NCT07725380Phase 1, Phase 24 sites📍 Tampa📍 St Louis📍 The Bronx H. Lee Moffitt Cancer Center and Research Institute · Tests: Domatinostat, Sirolimus A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) NCT07193550Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors NCT06926283Phase 14 sites📍 Changsha📍 Hangzhou📍 Beijing Hangzhou DAC Biotechnology Co., Ltd. · Tests: DXC008 Observational Study in Localized Osteosarcoma NCT04890067n/a16 sites📍 Aviano📍 Candiolo📍 Trieste Italian Sarcoma Group · Tests: Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any… Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial NCT07227571Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: FH FOLR1 ST CAR T-cells, Leukapheresis, Fludarabine, Cyclophosphamide, Echocardiography Test Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy NCT06599957n/a2 sites📍 Bologna📍 Meldola Istituto Ortopedico Rizzoli An Observational Study of Local Relapse After High Grade Osteosarcoma NCT06017518n/a2 sites📍 Bologna📍 Pisa Istituto Ortopedico Rizzoli Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors NCT07112989n/a1 site📍 Bologna Istituto Ortopedico Rizzoli Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery NCT05779670n/a1 site📍 Bologna Istituto Ortopedico Rizzoli Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma NCT07787429Phase 21 site📍 Warsaw Anna Raciborska · Tests: Mifamurtide, Sorafenib Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients NCT05051059NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Functional outcome, Health related quality of life (HRQoL) assessment 68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma NCT07774533EARLY Phase 11 site📍 Beijing Peking University First Hospital · Tests: 68Ga-B7-H3 Nanobody PET/CT A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma NCT06650514Phase 21 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: OMO-103 NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma NCT07211737Phase 11 site📍 Houston Baylor College of Medicine · Tests: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK cel… Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone NCT05033288n/a3 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Electronic Health Record Review, Quality-of-Life Assessment Clonal Hematopoiesis Chemotherapy and Radiation Effects Study NCT07675967n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) NCT06395103Phase 1, Phase 271 sites📍 Los Angeles📍 Aurora📍 New Haven Merck Sharp & Dohme LLC · Tests: Zilovertamab vedotin Musculoskeletal Cancers Remote Monitoring and Care NCT07129226NA1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Smart Watch Donor Site Morbidity After Free Vascularized Fibular Graft NCT06324916n/a1 site📍 Asyut Assiut University · Tests: Xray Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas NCT05210374Phase 11 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma NCT03721068Phase 12 sites📍 Atlanta📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine Lenvatinib for Advanced Bone and Soft Tissue Sarcoma NCT05617859Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Lenvatinib mesylate capsule Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites📍 San Francisco📍 Aurora📍 Philadelphia Children's Hospital of Philadelphia · Tests: Cabozantinib Clinical Applicability of Liquid Biopsy in Chondrosarcoma NCT07492823n/a1 site📍 Graz Medical University of Graz · Tests: laboratory biomarker analysis, Molecular pathology
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy